- Home
- ALTO vs SRZN Comparison
ALTO vs SRZN Comparison
Compare ALTO & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTO
- SRZN
- Stock Information
- Founded
- ALTO 2003
- SRZN 2015
- Country
- ALTO United States
- SRZN United States
- Employees
- ALTO N/A
- SRZN N/A
- Industry
- ALTO Major Chemicals
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- ALTO Industrials
- SRZN Health Care
- Exchange
- ALTO Nasdaq
- SRZN Nasdaq
- Market Cap
- ALTO 90.3M
- SRZN 72.8M
- IPO Year
- ALTO N/A
- SRZN N/A
- Fundamental
- Price
- ALTO $1.25
- SRZN $8.71
- Analyst Decision
- ALTO Strong Buy
- SRZN Strong Buy
- Analyst Count
- ALTO 1
- SRZN 2
- Target Price
- ALTO $5.50
- SRZN $38.50
- AVG Volume (30 Days)
- ALTO 307.0K
- SRZN 22.6K
- Earning Date
- ALTO 08-05-2025
- SRZN 08-11-2025
- Dividend Yield
- ALTO N/A
- SRZN N/A
- EPS Growth
- ALTO N/A
- SRZN N/A
- EPS
- ALTO N/A
- SRZN N/A
- Revenue
- ALTO $951,169,000.00
- SRZN $11,638,000.00
- Revenue This Year
- ALTO N/A
- SRZN N/A
- Revenue Next Year
- ALTO $7.68
- SRZN N/A
- P/E Ratio
- ALTO N/A
- SRZN N/A
- Revenue Growth
- ALTO N/A
- SRZN N/A
- 52 Week Low
- ALTO $0.76
- SRZN $5.90
- 52 Week High
- ALTO $2.05
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- ALTO 69.00
- SRZN 47.45
- Support Level
- ALTO $1.22
- SRZN $8.00
- Resistance Level
- ALTO $1.28
- SRZN $8.94
- Average True Range (ATR)
- ALTO 0.07
- SRZN 0.72
- MACD
- ALTO 0.01
- SRZN -0.07
- Stochastic Oscillator
- ALTO 95.73
- SRZN 27.14
About ALTO Alto Ingredients Inc.
Alto Ingredients Inc is a producer of specialty alcohols and essential ingredients. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include major food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, Western production, and Others.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).